Newsroom-Katalog
Zeit | Sysmex Inostics GmbH: Meldungen vom 15.10.2018 |
---|---|
13:10 | Sysmex Inostics' OncoBEAM(TM) liquid biopsy technology demonstrates utility for clinical management of melanoma patients undergoing treatment with targeted therapy and immune checkpoint inhibitors |